<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03181230</url>
  </required_header>
  <id_info>
    <org_study_id>17-0142</org_study_id>
    <secondary_id>UL1TR001082</secondary_id>
    <nct_id>NCT03181230</nct_id>
  </id_info>
  <brief_title>Health, Fitness, and Quality of Life in Adolescent Girls With Turner Syndrome</brief_title>
  <official_title>Pilot Study of Health, Fitness, and Quality of Life in Adolescent Girls With Turner Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study plans to learn more about how the energy system works in girls with Turner
      syndrome. This is important to know so that the investigators understand how Turner syndrome
      relates to diseases such as diabetes, extra weight gain, heart disease and liver disease, and
      how this impacts day to day life.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 26, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Peak oxygen consumption</measure>
    <time_frame>Baseline</time_frame>
    <description>Peak oxygen consumption (VO2 peak) with a standard graded exercise (bicycle) test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>Baseline</time_frame>
    <description>Self and parent reported quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent body fat</measure>
    <time_frame>Baseline</time_frame>
    <description>Body composition by dual-energy x-ray absorptiometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin resistance (IR)</measure>
    <time_frame>Baseline</time_frame>
    <description>Fasting insulin and glucose used to calculate homeostatic model assessment (HOMA)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Qualitative structured interview</measure>
    <time_frame>Baseline</time_frame>
    <description>Attitudes surrounding physical activity participation</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Turner Syndrome</condition>
  <condition>Turner Syndrome Mosaicism, 45, X/46, XX or XY</condition>
  <condition>Turner Syndrome Mosaicism 46,X,I(X)(Q10)/45,X</condition>
  <condition>Turner Syndrome Karyotype 46,X With Abnormal Sex Chromosome , Except I(Xq)</condition>
  <arm_group>
    <arm_group_label>Adolescents</arm_group_label>
    <description>Adolescents and young adults with Turner syndrome will undergo studies of cardiometabolism, fitness, quality of life questionnaires, and a brief interview.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Parents</arm_group_label>
    <description>One parent of a participant will complete parent-report quality of life questionnaires and a brief interview.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <description>No intervention</description>
    <arm_group_label>Adolescents</arm_group_label>
    <arm_group_label>Parents</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood (serum and plasma)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Investigators will enroll adolescent and young adult females with Turner syndrome who will
        complete all study procedures. One parent will also be enrolled (either mother or father)
        to complete questionnaires about the daughter.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female

          -  Age 12-21 years

          -  45,XO karyotype in &gt;50% of cells tested with a diagnosis of Turner syndrome (TS)

          -  Tanner stage 2-5 for breast development

        Exclusion Criteria:

          -  Growth hormone treatment within the past 3 months

          -  Diagnosis of type 1 or type 2 diabetes

          -  Untreated hypertension with blood pressure &gt; 99%ile for sex, age and height or &gt;140/90

          -  Weight &gt; 300 lbs

          -  Height &lt; 54&quot;

          -  Aortic sinus of Valsalva or ascending aorta z-score &gt; 2

          -  Other cognitive, psychiatric, or physical impairment resulting in inability to
             tolerate the study procedures, including vigorous exercise

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shanlee Davis, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colroado</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shanlee Davis, MD, MS</last_name>
    <phone>720-777-6073</phone>
    <email>shanlee.davis@childrenscolorado.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amira Herstic, MS</last_name>
    <phone>720-777-6774</phone>
    <email>Amira.herstic@childrenscolorado.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shanlee M Davis, MD</last_name>
      <phone>720-777-6073</phone>
      <email>shanlee.davis@childrenscolorado.org</email>
    </contact>
    <contact_backup>
      <last_name>Susan Howell, MS, CGC, MBA</last_name>
      <phone>720-777-8361</phone>
      <email>susan.howell@childrenscolorado.org</email>
    </contact_backup>
    <investigator>
      <last_name>Shanlee M Davis, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicole Tartalia, MD, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Amira Herstic, MS, CGC, MBA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kristen Nadeau, MD, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2017</study_first_submitted>
  <study_first_submitted_qc>June 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 8, 2017</study_first_posted>
  <last_update_submitted>October 4, 2017</last_update_submitted>
  <last_update_submitted_qc>October 4, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Turner syndrome</keyword>
  <keyword>45,XO</keyword>
  <keyword>body composition</keyword>
  <keyword>cardiometabolism</keyword>
  <keyword>quality of life</keyword>
  <keyword>fitness</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Turner Syndrome</mesh_term>
    <mesh_term>Gonadal Dysgenesis</mesh_term>
    <mesh_term>Primary Ovarian Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

